drug
revers
epigenet
silenc
dna
methyltransferas
inhibitor
dnmti
aza
profound
effect
transcript
tumor
cell
surviv
aza
approv
drug
myelodysplast
syndrom
acut
myeloid
leukemia
investig
differ
solid
malign
tumor
aza
treatment
gener
self
doublestrand
rna
dsrna
transcrib
hypomethyl
repetit
element
self
dsrna
accumul
dnmtitreat
cell
lead
type
ifn
product
ifnstimul
gene
express
report
cell
death
respons
aza
treatment
occur
synthetas
oa
rnase
l
pathway
oass
ifninduc
enzym
synthes
rnase
l
activ
respons
dsrna
cell
defici
rnase
l
highli
resist
aza
wildtyp
cell
treat
smallmolecul
inhibitor
rnase
l
smallmolecul
inhibitor
cjun
nh
termin
kinas
jnk
also
antagon
rnase
ldepend
cell
death
respons
aza
consist
role
jnk
rnase
linduc
apoptosi
contrast
rate
azainduc
rnase
ldepend
cell
death
increas
transfect
defici
edit
destabil
dsrna
degrad
ioniz
radiat
induc
ifndepend
signal
final
express
correl
aza
sensit
set
tumor
cell
line
suggest
level
biomark
predict
aza
sensit
tumor
cell
studi
may
eventu
lead
pharmacolog
strategi
regul
antitumor
activ
toxic
aza
relat
drug
na
methyltransferas
inhibitor
dnmti
investig
potenti
cancer
therapeut
agent
least
methyl
cytosin
residu
cpg
island
dna
result
epigenet
silenc
transcript
remov
methyl
group
opposit
effect
promot
transcript
current
dnmti
aza
dac
approv
myelodysplast
syndrom
also
improv
surviv
acut
myeloid
leukemia
addit
dnmti
investig
treatment
variou
solid
tumor
includ
nonsmallcel
lung
cancer
nsclc
breast
colorect
cancer
dnmti
deplet
cellular
level
dna
methyltransferas
lead
dna
hypomethyl
widerang
effect
cancer
cell
howev
remain
critic
need
better
understand
molecular
mechan
antitumor
cytotox
effect
dnmti
increas
clinic
efficaci
minim
toxic
studi
cancer
therapeut
mechan
dnmti
includ
aza
focus
induct
tumor
suppressor
gene
recent
express
self
doublestrand
rna
dsrna
dna
demethyl
caus
treatment
nanomolar
level
dnmti
induc
bidirect
transcript
human
endogen
retroviru
erv
like
gene
lead
format
dsrna
ifn
respons
inhibit
cell
prolifer
dsrna
common
viral
pathogenassoci
molecular
pattern
induc
innat
immun
respons
includ
express
type
ifn
ifnstimul
gene
isg
therefor
express
self
dsrna
account
longknown
observ
dnmti
induc
isg
howev
connect
self
dsrna
induct
aza
tumor
cell
death
induc
dnmti
less
clear
synthetas
oa
rnase
l
pathway
ifnstimul
antivir
respons
requir
dsrna
type
type
iii
ifn
induc
transcript
famili
human
oa
gene
encod
enzymat
activ
isozym
enzymat
inact
oasl
dsrna
bind
activ
use
atp
synthes
seri
oligoadenyl
wellestablish
function
activ
singlestrand
rnaspecif
endoribonucleas
signific
drug
caus
epigenet
modif
dna
aza
use
clinic
treat
myelodysplast
syndrom
acut
myeloid
leukemia
addit
aza
investig
use
rang
differ
type
solid
tumor
includ
lung
colorect
cancer
treatment
aza
caus
demethyl
dna
thu
increas
rna
synthesi
includ
synthesi
doublestrand
rna
otherwis
produc
virusinfect
cell
determin
cell
death
respons
aza
requir
antivir
enzym
rnase
l
result
identifi
drug
target
enhanc
anticanc
activ
reduc
toxic
aza
relat
drug
rnase
l
bind
inact
latent
monomer
form
rnase
l
induc
dimer
activ
also
requir
atp
adp
bind
protein
kinaselik
domain
rnase
l
activ
rnase
l
cleav
viral
cellular
rna
suppress
viral
replic
part
elimin
virusinfect
cell
apoptosi
self
dsrna
accumul
dnmti
treatment
also
mutat
dsrnaedit
enzym
lead
genet
diseas
syndrom
previous
report
crisprmedi
knockout
rnase
l
prevent
lethal
effect
delet
nsclc
cell
convert
adenosin
inosin
destabil
dsrna
prevent
reduc
activ
oa
indirectli
also
suppress
rnase
l
activ
togeth
presenc
dsrna
ifn
isg
express
includ
oass
dnmtitreat
cell
requir
rnase
l
cell
death
due
knockout
led
us
examin
whether
rnase
l
contribut
elimin
cancer
cell
dnmti
report
cell
lack
rnase
l
protect
cytotox
effect
aza
furthermor
smallmolecul
inhibitor
either
rnase
l
cjun
nh
termin
kinas
jnk
implic
rnase
lmediat
apoptosi
protect
cell
aza
convers
delet
pde
degrad
delet
edit
destabil
dsrna
ioniz
radiat
ir
activ
ifndepend
signal
increas
rnase
ldepend
cytotox
effect
aza
basal
express
set
human
tumor
cell
line
correl
aza
sensit
find
suggest
potenti
target
enhanc
antitumor
activ
mitig
toxic
aza
cell
lack
rnase
l
resist
aza
treatment
dnmti
induc
accumul
self
dsrna
sever
differ
tumor
cell
type
confirm
observ
nsclc
cell
treat
aza
h
visual
cytoplasm
dsrna
accumul
monoclon
antibodi
dsrna
si
appendix
fig
detect
dsrna
untreat
cell
accumul
dsrna
cytoplasm
appar
aza
treatment
determin
whether
rnase
l
affect
aza
sensit
compar
parent
vector
control
cell
wild
type
wt
rnase
l
knockout
ko
cell
previous
gener
technolog
si
appendix
fig
cell
treat
differ
amount
aza
monitor
surviv
function
time
use
incucyt
realtim
cell
imag
system
essen
bioscienc
dualdy
method
major
wt
cell
appear
dead
h
aza
treatment
azatr
rnase
l
ko
cell
appear
normal
fig
ad
quantif
wt
cell
surviv
show
cell
die
h
respons
aza
respect
fig
cell
death
wt
cell
observ
concentr
aza
greater
contrast
rnase
l
ko
cell
highli
resist
aza
h
littl
death
fig
confirm
rnase
l
respons
aza
sensit
rnase
l
ko
cell
transient
transduc
lentivir
construct
encod
either
wt
nucleasedead
mutant
rnase
l
fig
knockin
kin
wt
rnase
l
sensit
cell
aza
lead
decreas
cell
surviv
wherea
introduct
mutant
rnase
l
diminish
effect
cell
surviv
fig
result
demonstr
azainduc
cell
death
requir
rnase
l
function
catalyt
domain
individu
isoform
suffici
increas
azainduc
cell
death
immort
human
mammari
epitheli
hme
cell
also
render
highli
resist
aza
knockout
rnase
l
fig
ac
rel
contribut
differ
oa
isoform
azainduc
cell
death
determin
doubleknockout
dko
hme
cell
express
one
three
enzymat
compet
oa
isoform
dko
cell
lack
express
respect
fig
surviv
differ
type
untreat
cell
unaffect
oa
dko
tripleknockout
tko
genotyp
fig
e
h
interestingli
express
three
oa
isoform
render
hme
cell
nearli
sensit
aza
wt
cell
fig
howev
compar
wt
cell
hme
cell
lack
three
oa
isoform
name
tko
cell
rel
resist
aza
effect
mav
aza
sensit
dsrna
signal
type
ifn
gene
requir
pathway
therefor
determin
whether
ifn
product
subsequ
oa
induct
requir
azainduc
cell
death
cell
mav
knock
individu
combin
rnase
l
use
si
appendix
fig
mav
ko
cell
slightli
less
sensit
aza
treatment
wt
cell
suggest
although
ifn
product
may
contribut
azamedi
cell
death
effect
modest
si
appendix
fig
b
c
howev
rnase
lmav
dko
cell
resist
aza
concentr
high
si
appendix
fig
similar
rnase
l
ko
cell
fig
result
suggest
basal
data
averag
sd
three
ident
treat
replic
two
biolog
replic
perform
minimum
three
technic
replic
p
p
level
cell
confirm
gene
express
analysi
si
appendix
tabl
suffici
cellleth
effect
aza
rnase
l
activ
aza
caus
apoptot
death
cell
determin
mode
cell
death
aza
activ
monitor
marker
apoptosi
realtim
imag
incucyt
system
softwar
fig
wt
cell
activ
strongli
respons
aza
rnase
l
ko
cell
resist
aza
fig
b
mav
ko
cell
show
modest
reduct
activ
wherea
rnase
lmav
dko
cell
highli
resist
similar
rnase
l
singleko
cell
fig
bd
posit
control
pancaspas
inhibitor
zvadfmk
greatli
suppress
activ
expect
confirm
aza
treatment
induc
apoptosi
parp
cleavag
monitor
western
assay
treatment
wt
cell
aza
h
result
cleav
parp
fig
contrast
ident
treatment
rnase
l
ko
cell
lead
parp
poli
adpribos
polymeras
cleavag
thu
aza
induct
activ
parp
cleavag
wt
rnase
l
ko
cell
indic
cell
death
occur
proapoptot
activ
rnase
l
death
valid
involv
rnase
l
azamedi
cell
death
potent
smallmolecul
inhibitor
rnase
l
valon
acid
dilacton
val
use
treatment
cell
val
protect
cytotox
effect
aza
fig
b
similarli
val
suppress
activ
respons
aza
show
apoptosi
prevent
chemic
inhibit
rnase
l
fig
previous
report
rnase
l
activ
trigger
phosphoryl
jnk
also
jnkdefici
cell
resist
rnase
lmediat
apoptosi
accordingli
azainduc
cell
death
inhibit
treat
wt
cell
jnk
inhibitor
fig
rnase
l
ko
cell
resist
aza
absenc
presenc
inhibitor
fig
rescu
cell
death
jnk
inhibitor
implic
jnk
rnase
ldepend
mechan
apoptosi
respons
aza
treatment
cell
death
respons
aza
degrad
cell
action
therefor
increas
accumul
rnase
l
activ
aza
treatment
gene
encod
knock
cell
individu
combin
fig
previous
ablat
either
increas
level
retard
degrad
delet
slightli
increas
celldeath
rate
presenc
aza
wherea
knockout
much
larger
effect
fig
dko
greatli
increas
cell
death
respons
aza
fig
result
suggest
extend
halflif
cell
deplet
inhibit
catabol
enzym
increas
sensit
aza
fig
contrast
rnase
l
ko
cell
complet
resist
aza
combin
agent
fig
result
demonstr
exogen
increas
cellleth
effect
aza
mechan
action
entir
depend
rnase
l
knockout
increas
suscept
cell
aza
edit
adenosin
inosin
dsrna
destabil
dsrna
u
base
pair
stabl
u
mismatch
prior
studi
suggest
accumul
constitut
produc
self
dsrna
ko
cell
lead
oasrnas
l
activ
cell
death
knockout
lethal
cell
necessari
use
combin
knockout
cell
experi
determin
whether
antagon
cellleth
effect
aza
cell
differ
mav
rnase
l
genotyp
treat
aza
western
blot
cell
line
shown
percent
cell
surviv
wt
tko
hme
cell
either
h
untreat
treat
aza
data
averag
sd
three
ident
treat
technic
replic
four
biolog
replic
perform
minimum
three
technic
replic
p
si
appendix
fig
ifn
use
induc
level
lesser
extent
also
induc
aza
si
appendix
fig
cell
lmav
tko
l
dko
resist
aza
fig
contrast
dko
cell
show
increas
aza
sensit
compar
wt
cell
presum
increas
accumul
self
dsrna
due
absenc
fig
determin
rel
contribut
isoform
cell
lack
ifninduc
isoform
compar
wt
cell
fig
si
appendix
fig
ko
cell
sensit
aza
suggest
primarili
involv
azainduc
cytotox
result
indic
aza
sensit
cell
increas
defici
manner
ir
induc
type
ifn
signal
oa
gene
includ
ifnrel
dna
damag
resist
signatur
whose
express
correl
radiat
resist
cancer
cell
determin
effect
ir
azamedi
cell
death
oasrnas
l
pathway
wt
rnase
l
ko
cell
expos
gy
ir
either
mocktreat
treat
aza
fig
hj
kinet
cell
death
determin
realtim
cell
imag
effect
cell
viabil
ir
treatment
alon
wt
rnase
l
ko
cell
cell
rel
resist
radiat
fig
howev
combin
aza
ir
significantli
increas
celldeath
rate
wt
cell
compar
aza
treatment
alon
wherea
rnase
l
ko
cell
resist
ir
aza
fig
j
result
suggest
ir
increas
rnase
ldepend
cell
death
trigger
aza
treatment
express
set
human
tumor
cell
line
determin
whether
aza
sensit
correl
oasrnas
l
level
differ
tumor
cell
type
interrog
gene
express
profil
databas
human
tumor
cell
line
presenc
absenc
aza
fig
si
appendix
tabl
cell
line
repres
histolog
genet
divers
cancer
express
level
fig
oasl
fig
predict
sensit
aza
higher
express
level
enzym
greater
sensit
cell
lethal
effect
aza
result
suggest
level
particular
marker
sensit
azainduc
cytotox
oasrnas
l
pathway
mediat
tumor
cell
death
respons
aza
dnmti
long
known
induc
ifn
respons
character
isg
express
although
molecular
mechan
recent
elucid
hypomethyl
dna
result
dnmti
treatment
lead
product
self
dsrna
erv
short
interspers
nuclear
element
sine
repetit
dna
element
trigger
innat
immun
respons
resembl
respons
induc
viral
infect
ko
absenc
viral
infect
dsrna
signal
pathway
induc
type
iii
ifn
turn
induc
express
isg
includ
mediat
biolog
effect
ifn
exampl
dac
shown
induc
ifn
respons
colorect
canceriniti
cell
cic
signal
pathway
longterm
growth
cic
inhibit
follow
transient
treatment
low
dose
dac
similarli
cellular
respons
dnmti
aza
dac
character
high
express
erv
ifn
sensit
melanoma
immunotherapi
dsrna
also
directli
activ
two
type
ifninduc
enzym
protein
kinas
pkr
block
translat
initi
synthes
activ
rnase
l
wellestablish
function
activ
rnase
l
antivir
protein
proapoptot
activ
observ
delet
rnase
l
isoform
render
cell
highli
resist
azainduc
death
result
contrast
consequ
viral
infect
cell
domin
oa
isoform
least
cell
type
addit
demethyl
dna
aza
treatment
lead
rna
demethyl
increas
rna
immun
signal
howev
depend
dsrnaactiv
oasrnas
l
pathway
azainduc
cell
death
suggest
dna
demethyl
lead
dsrna
rna
demethyl
respons
cytotox
respons
rnase
l
caus
apoptosi
ribotox
stress
pathway
involv
jnkdepend
signal
consist
involv
rnase
l
azainduc
cell
death
observ
smallmolecul
inhibitor
jnk
suppress
apoptosi
respons
aza
previous
azainduc
cytotox
link
revers
dna
damag
stem
format
coval
complex
dna
dnmt
also
dna
damag
induc
ir
chemotherapeut
agent
small
noncod
rna
accumul
cytoplasm
activ
pathogen
recognit
receptor
rigi
ifndepend
signal
support
idea
show
ir
increas
cytotox
aza
rnase
l
interestingli
mani
differ
primari
malign
tumor
includ
head
neck
lung
prostat
breast
highgrad
glioma
express
high
level
oa
express
part
ifnrel
dna
damag
resist
signatur
therefor
azainduc
cell
death
oasrnas
l
like
preferenti
target
cancer
cell
vivo
chemic
genet
induc
self
dsrna
trigger
activ
oasrnas
l
cell
death
genet
defici
dsrnaedit
enzym
lead
rnase
ldepend
death
ifnstimul
translat
arrest
pkr
similar
cellular
effect
aza
treatment
mutat
lead
format
self
dsrna
transcrib
repetit
dna
element
includ
alu
sine
herv
element
mutat
defici
self
dsrna
edit
believ
lead
increas
activ
oasrnas
l
wherea
aza
treatment
like
increas
transcript
repetit
dna
element
caus
oasrnas
l
activ
sinc
delet
lethal
cell
use
dko
cell
experi
knockout
aza
treatment
result
synthesi
self
dsrna
combin
defici
aza
treatment
especi
cytotox
mav
requir
azainduc
cell
death
induct
type
ifn
dsrna
occur
signal
pathway
determin
whether
pathway
requir
azainduc
cell
death
mav
ko
cell
studi
mav
delet
reduc
prevent
cell
death
oasrnas
l
respons
aza
treatment
result
similar
find
ko
cell
therefor
basal
level
oa
isozym
suffici
mediat
cell
death
rnase
l
activ
fig
si
appendix
tabl
prior
studi
mous
hepat
viru
show
mous
bone
marrow
macrophag
basal
level
oa
suffici
rnase
l
activ
taken
togeth
result
reveal
ifn
need
induc
antivir
celldeath
respons
oasrnas
l
provid
suffici
basal
level
oa
rnase
l
present
furthermor
correl
basal
oasl
level
aza
sensit
tumor
cell
panel
indic
oasl
biomark
aza
sensit
cancer
dnmti
rnase
l
cancer
prior
studi
antitumor
activ
aza
dac
show
effect
melanoma
increas
immun
checkpoint
therapi
colorect
cancer
target
colorect
canceriniti
cell
also
earlier
studi
show
dac
could
overcom
resist
ifninduc
apoptosi
renal
carcinoma
melanoma
dnmti
treatment
mous
cell
mutant
led
massiv
dsrna
accumul
origin
least
part
transcript
repetit
dna
element
culmin
cellsuicid
type
ifn
respons
transcrib
repetit
dna
element
includ
sine
satellit
repeat
endogen
iap
retrovir
dna
noncod
rna
gene
howev
hme
cell
type
yet
azasensit
fig
basal
oasl
express
correl
aza
sensit
among
tumor
cell
line
drug
sensit
aza
repres
gi
drug
concentr
result
growth
reduct
quantifi
measur
total
rna
day
raw
data
download
nation
cancer
institut
develop
therapeut
program
dtpncinih
gov
higher
gi
indic
less
sensit
drug
gi
correl
express
oasl
b
cell
line
gene
express
valu
microarray
gene
express
omnibu
databas
access
probe
set
oasl
statist
method
spearman
rank
correl
coeffici
test
calcul
use
sa
softwar
data
averag
sd
three
ident
replic
three
biolog
replic
perform
minimum
three
technic
replic
hj
percent
cell
surviv
ir
gy
min
follow
aza
treatment
comparison
mock
treatment
data
averag
sd
three
ident
replic
two
biolog
replic
perform
minimum
three
technic
replic
p
p
therefor
aza
sensit
involv
rnase
l
azainduc
cell
death
limit
cell
mutant
least
human
cell
type
examin
studi
find
suggest
strategi
increas
anticanc
effect
aza
instanc
combin
aza
ir
highli
effect
elimin
tumor
cell
rnase
ldepend
manner
also
show
knockout
impair
degrad
increas
tumor
cell
kill
aza
therefor
treatment
increas
rnase
l
activ
directli
indirectli
instanc
inhibit
andor
predict
increas
antitumor
activ
aza
dac
altern
inhibitor
rnase
l
val
expect
mitig
cytotox
aza
therefor
studi
therapeut
implic
either
increas
efficaci
dnmti
treatment
cancer
mitig
toxic
detail
materi
method
construct
gene
knockout
cell
immunoblot
procedur
celldeath
assay
assay
ir
immunofluoresc
statist
describ
si
appendix
